REGN vs WAFDP · P/E 14, rev $4.29B vs P/E 5.9, $2.32B cap
Regeneron Pharmaceuticals Inc (REGN) versus WaFd, Inc. (WAFDP) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
WaFd, Inc. (WAFDP) is a banks - regional company listed on NASDAQ.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
WAFDP does not have a complete income-statement cache yet.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WAFDP currently screens at market cap $2.32B and trailing P/E 5.9.
Not investment advice. Open the REGN and WAFDP stock pages for the full models.
Not investment advice.